|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $109,097,534 | $136,444,157 | $185,585,307 | $190,364,369 | $199,354,261 | $167,380,770 | $191,213,146 |
| Streptomycins & their derivs.; salts thereof | $1,743,877 | $1,516,061 | $1,532,190 | $1,523,567 | $1,499,129 | $1,290,852 | $2,194,041 |
| Tetracyclines & their derivs.; salts thereof | $91,176,195 | $90,995,460 | $51,444,641 | $38,368,141 | $23,430,855 | $34,105,930 | $52,519,017 |
| Chloramphenicol & its derivs.; salts thereof | $905,349 | $961,567 | $919,366 | $1,308,766 | $1,298,545 | $1,991,866 | $1,798,617 |
| Erythromycin & its derivs.; salts thereof | $217,633,720 | $144,879,747 | $204,270,865 | $235,714,665 | $130,108,467 | $62,070,079 | $35,272,758 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $996,440,503 | $1,351,494,546 | $1,516,016,100 | $1,252,159,303 | $1,349,196,921 | $1,377,304,143 | $1,622,432,313 |
| Total | $1,416,997,178 | $1,726,291,538 | $1,959,768,469 | $1,719,438,811 | $1,704,888,178 | $1,644,143,640 | $1,905,429,892 |
|
|
